Results 41 to 50 of about 670,295 (308)
BMJ, 1992 Summary We are gaining a clearer insight into the causes and mechanisms of gastric carcinogenesis, and may be able to reduce the incidence in the future by Helicobacter pylori eradication, perhaps in conjunction with nutritional supplements.
openaire +5 more sources
MedComm, 2023 Drug resistance remains the greatest challenge in improving outcomes for cancer patients who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a subpopulation of cancer cells could escape intense selective drug treatment by ...
Xiaohai Song +13 more
doaj +1 more source
Early gastric cancer mimicking advanced gastric cancer [PDF]
British Journal of Cancer, 1997 The clinicopathological features of 37 early gastric cancers mimicking advanced gastric cancer were reviewed retrospectively, and were compared with 596 other early gastric cancers and 126 mp gastric cancers, defined as gastric cancer invading the muscularis propria of the stomach.
K, Kitamura +8 more
openaire +2 more sources
Gut and Liver, 2017 Background/AimsDelayed bleeding after gastric endoscopic submucosal dissection (ESD) commonly occurs within 3 days, but it may also occur after 1 week following ESD, especially in antiplatelet agent users.
Jong Yeul Lee +4 more
doaj +1 more source
Recurrence after ESD curative resection for early gastric cancer
Surgical Case Reports, 2021 Background Endoscopic submucosal dissection (ESD) is gaining ground as a minimally invasive treatment for early gastric cancer (EGC) that has a negligible risk of lymph node metastasis.
Ayako Kamiya +12 more
doaj +1 more source
Occurrence of gastric cancer and carcinoids in atrophic gastritis during prospective long-term follow up [PDF]
, 2015 Objective. Atrophic gastritis (AG) is a risk condition for gastric cancer and type I gastric carcinoids. Recent studies assessing the overall risk of gastric cancer and carcinoids in AG at long-term follow up are lacking.
Annibale, Bruno +6 more
core +2 more sources
BMC Gastroenterology, 2021 Background This randomized, open-label trial aimed to compare the efficacy of 10-day bismuth-containing quadruple therapy (BQT) with 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT) as an empirical first-line ...
Young-Il Kim +5 more
doaj +1 more source
The esophagogastric junctional adenocarcinoma an increasing disease [PDF]
, 2017 Identifying and defining the esophagogastric junctional adenocarcinoma (EGJA) as an independent disease apart from gastric cancer (GC) and esophagus cancer (EG) it has always been a difficult issue entailing doubts about the appropriate therapeutic ...
Andreetti, Claudio +3 more
core +1 more source
Treatment of helicobacter pylori infection in atrophic gastritis [PDF]
, 2018 Helicobacter pylori (Hp) is a major human pathogen causing chronic, progressive gastric mucosal damage and is linked to gastric atrophy and cancer. Hp-positive individuals constitute the major reservoir for transmission of infection.
Annibale, B, Carabotti, M, Lahner, E
core +1 more source
Gastric Microbiome and Gastric Cancer [PDF]
The Cancer Journal, 2014 Cancer of the stomach is the fourth most common cancer worldwide. The single strongest risk factor for gastric cancer is Helicobacter pylori-associated chronic gastric inflammation. Among persons with H. pylori infection, strain-specific components, host immune responses, and environmental factors influence the risk for gastric disease, including ...
Kyle M, Brawner +2 more
openaire +2 more sources